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Multiple SARS-CoV-2 vaccinations have shown excellent efficacy during clinical trials. However, post 14 
vaccine surveillance is important to confirm ‘real-world’ findings of vaccine efficacy and safety.  It is 15 
therefore imperative to identify individuals that become infected with SARS-CoV-2 post vaccination. 16 
We investigated the vaccination status of staff that had tested positive in a cohort of healthcare 17 
workers in one large tertiary hospital in the UK.  At the time of the investigation, 8th December 2020 18 
to 13th March 2021, 11,871 staff had been vaccinated and 225 staff tested positive for SARS-CoV-2.   19 
This period coincided with the second wave of SARS-CoV-2 infections in the UK which was driven by 20 
the Alpha variant.   No healthcare workers who were double vaccinated had a positive PCR test for 21 
SARS-CoV-2 during this study period confirming vaccination with Pfizer BioNTec BNT162b2 gives 22 
excellent protection against infection of this variant.   23 
 24 
Introduction 25 
On the 8th December 2020 the world’s first dose of COVID-19 vaccine, was given to a recipient 26 
outside of clinical trials.  This dose of Pfizer BioNTec BNT162b2 was administered at University 27 
Hospital Coventry and Warwickshire NHS Trust (UHCW), a large tertiary hospital located in the West 28 
Midlands, England. Healthcare workers who receive their vaccine on the hospital site are only 29 
offered the Pfizer BioNTec BNT162b2. In rare circumstances where the Pfizer vaccination was 30 
contraindicated due to history of severe allergy, staff may have been vaccinated elsewhere with the 31 
AstraZeneca (ChAdOx1).  At the time of this study these were the only two vaccines available in the 32 
         
UK.  Clinical trial data for the Pfizer vaccination recommended an interval of 21 days between first 33 
and second doses of vaccine and vaccine induced protection is considered to be achieved 14 days 34 
after the first vaccine dose. On the 30th December 2020 the Joint Committee on Vaccination and 35 
Immunisation (JCVI) decided to amend the vaccine schedule extent the interval between doses to  36 
12 weeks, allowing more people to receive at least one dose of vaccine to maximise the short term 37 
impact at a time when cases of SARS-CoV-2 in the UK were high [1].  The subsequent speed at which 38 
the vaccination programme in the UK has been rolled has been phenomenal.  As of May 2021 39 
36,704,672 first doses and 20,287,403 second doses have been administered nationally  [2].  40 
Throughout the pandemic it has been clear that front-line healthcare workers are at high risk of 41 
acquiring SARS-CoV-2 infection and transmitting infection onto vulnerable groups of patients [3]. 42 
Due to this increased risk, healthcare workers were placed second on the JCVI prioritisation list [4].  43 
Some healthcare workers who presented early for vaccine in the UK received 2 doses of BNT162b2 44 
prior to the change in schedule.   Post vaccine surveillance is important to confirm ‘real-world’ 45 
findings of vaccine efficacy and safety demonstrated within clinical trial settings, especially when the 46 
recommended regimen has been adapted.  It is therefore imperative to identify individuals that 47 
become infected with SARS-CoV-2 post vaccination to better understand protection offered by 48 
vaccination and the signs and symptoms of disease in this cohort.   49 
 50 
The SIREN study looked to understand impact of vaccination in healthcare workers in a group of staff 51 
who were undergoing regular asymptomatic screening for SARS-CoV-2 [5].  The roll-out of the 52 
vaccination programme requires further investigation as to the impact on the incidence of COVID-19 53 
in healthcare workers to extend on the work that has been done by the SIREN study.  Here we 54 
present the data from an audit of vaccination status of staff members at UHCW, who tested positive 55 
for SARS-CoV-2 by PCR between 8th December 2020 and 13th March 2021.  This audit was carried out 56 
in the midst of the second wave in the UK which peaked in the last week of January 2021, the 57 
predominant variant in the UK at this time was Alpha (B.1.1.7).   58 
         
Materials and Methods 59 
 60 
UHCW is a tertiary university hospital of 1250 beds covering a wide range of specialities.  There are 61 
approximately 13,000 staff who work across the organisation.  Positive SARS-CoV-2 PCR test results 62 
from staff tested at UHCW were extracted from the laboratory information system covering the 63 
period of the 8th December 2020 to the 13th March 2021.  Staff that had positive SARS-CoV-2 PCR 64 
results from a nasopharyngeal and throat swab were cross-referenced with vaccination data to 65 
identify which of those staff who had tested positive during this period had received at least one 66 
dose of vaccine. 67 
  68 
Staff who tested positive >14 days after their first dose of vaccination were contacted to participate 69 
in a survey relating to their positive SARS-CoV-2 PCR result.  The survey was conducted in April 2021 70 
one month after the data collection period ended.  Time from infection to answering the survey 71 
ranged from 1 -4 months, dependent on when they tested positive for SARS-CoV-2.  The survey was 72 
delivered via telephone or email and captured information on job role, ethnicity, reason for seeking 73 
a SARS-CoV2 test, symptom timelines and any known contacts with a positive case of SARS-CoV-2. 74 
 75 
Under the Governance Arrangements for Research Ethics Committees (GAfREC), studies where staff 76 
are being approached due to the nature of their role are exempt from requiring Research Ethics 77 
Committee (REC) approval. Therefore, local R&D approval was obtained via the COVID-19 Research 78 






         
Results and Discussion 85 
 86 
Two hundred and twenty five staff that had tested positive for SARS-CoV-2 between the 87 
8th December 2020 and 14th March 2021 were identified.  Twelve staff were excluded due to inability 88 
to ascertain their vaccination status, reducing the cohort to 213 individuals (figure 1).  89 
 90 
Of the 213 staff with a positive SARS-CoV-2 PCR test, 70 (33%) individuals had not received a single 91 
COVID-19 vaccination dose.  Eighty four (39%) individuals had received a single dose of vaccine after 92 
their positive SARS-CoV-2 result. Therefore, no protection from vaccination would have been 93 
expected at the time they tested positive. 94 
 95 
Fifty-nine staff (28%) had received their first dose of vaccine between 2 to 69 days before they 96 
tested positive for SARS-CoV-2.  Of the 59 staff who received their vaccine prior to testing positive 97 
for SARS-CoV-2; Thirty three of these individuals tested positive for SARS-CoV-2 within 10 days of 98 
vaccination and were therefore most likely incubating the virus at the time of vaccination. Three 99 
staff tested positive at 10-14 days after vaccine administration so possibly incubating at the time of 100 
vaccination or shortly after having received the vaccine but would not have had sufficient time to 101 
mount a protective immune response.   102 
 103 
Twenty three staff members were vaccinated >14 days before they tested positive for SARS-CoV-2 104 
(range 15-69 days), and therefore failed to be protected from infection following a single vaccine 105 
dose (figure 1 and 2). All 23 health care workers had received Pfizer-BioNTech BNT162b2 106 
vaccination.  These 23 staff members were contacted and asked to partake in a survey regarding 107 
their infection. Seventeen responses were received (table I).  108 
 109 
         
The majority of staff members were white British (76%). The most common reason for having a PCR 110 
test was due to ward outbreak surveillance screening (8) , followed by symptomatic screens (5), 111 
confirmation of positive asymptomatic lateral flow testing (3) and finally social contact with a 112 
positive case (1). The time from vaccination to become positive ranged from 15-69 days, with a 113 
median of 22.5 days.  Three (17.6%) of the 17 staff members surveyed stated that they were 114 
asymptomatic at the time of testing and did not go onto develop any symptoms attributable to 115 
SARS-CoV 2 at all after their positive SARS-CoV-2 test. The remaining 14 staff members either had 116 
symptoms at the time of the testing, or developed symptoms in the 3 days after their test. None of 117 
these staff required medical intervention or hospitalisation.  Ten staff members stated that they 118 
thought the transmission had occurred due to positive patient contact. Five staff members had 119 
contact with a positive household case. Two staff members had no known contact with individuals 120 
known to be infected with SARS-CoV-2.  Surveys were conducted at the end of the study period, and 121 
therefore depending upon when the infection took place, there may be an element of recall bias 122 
when gathering information from study participants.  123 
 124 
Cycle threshold (CT) values in SARS-CoV-2 infected individuals can range from low to high and is 125 
dependent on multiple factors; including the time the swab was taken in relation to the infectious 126 
period and the swabbing technique.   It can be used as a crude indication of the amount of virus 127 
present in the oro/nasopharynx at the time of swabbing with a low CT value indicating a high level of 128 
viral RNA.  CT values were reviewed from all positive SARS-CoV-2 PCR tests in this cohort and ranged 129 
from 16-35.  Two individuals had swabs with CT values of <20 and could be considered to have a 130 
relatively high amount of viral RNA.  Fifteen individuals had swabs with CT values ranging from 20-35 131 
and could be considered to have a relatively low amount of viral RNA.  Inferring a viral burden from 132 
CT values must be done with caution as a standard curve was not used.  However, the fact that the 133 
majority of these staff members had swabs with relatively low amounts of viral RNA is an 134 
observation that requires further investigation to ascertain whether this is a vaccine affect or not.  135 
         
This observation has been noted in other studies whereby vaccinated individuals have a reduction in 136 
the amount of virus detected by PCR [6]. 137 
    138 
It is of note that there was a significant number of staff (70; 32.9%) who had not at the time of the 139 
audit received a single dose of vaccine, when it had been available to them for approximately 3 140 
months.  While it is recommended to wait a minimum of 4 weeks after a positive test before 141 
receiving the COVID-19 vaccine [7], these staff tested positive >4 weeks before their vaccination 142 
status was ascertained.  Interestingly the SIREN study also noted that vaccine coverage was 143 
significantly reduced in HCW’s who had had prior infection with SARS-CoV-2 [5].  It would be 144 
interesting to explore the reasoning of HCW’s reluctance to present for vaccination post-infection.  145 
Perhaps this is because of a fear of side effects; It has been observed that people who are vaccinated 146 
after natural infection have more severe but still self-limiting flu-like symptoms post vaccination 147 
compared to SARS-CoV-2 naive counterparts [8] .  It may also be that staff who have been infected 148 
with SARS-CoV-2 are not presenting for vaccination due to altruistic reasons; they have antibodies to 149 
SAR-CoV-2 and are therefore choosing to delay their vaccination so someone else can go first.  Data 150 
from SIREN interim analysis suggests that immunity from natural infection lasts at least 7 months in 151 
HCW’s [9], therefore these individuals not being vaccinated at this stage of the pandemic is unlikely 152 
to have an impact on the national goal of reaching a level of population immunity that will reduce 153 
the number of hospitalisations associated with COVID-19.  It must be noted that this is a cohort who 154 
are <65 years of age and whether this duration of protection can be extrapolated to those >65 or to 155 
those with underlying health conditions is unclear.  This hesitancy in health care workers who have 156 
had a previous infection with SARS-CoV-2 to present for vaccination may need to be considered 157 
when designing communication strategies around vaccination and vaccine hesitancy in healthcare 158 
settings.    159 
 160 
         
As of the 13th March 2021, 11,871 staff at UHCW had been vaccinated. Of those, 9488 had only one 161 
dose and 2383 staff had received both doses.   Four hundred and fifty six staff received their first 162 
dose between the 28th February and the 13th March and would not have been considered protected 163 
during this audit period.  Therefore this gives us an infection rate of 0.2% in our vaccinated cohort 164 
(23/11,415), and all staff that became infected had only received one dose of vaccine (Pfizer BioNTec 165 
BNT162b2).  It should be noted we may be slightly under reporting the number of the infections in 166 
our staff cohort as some people may have chosen to be tested at an alternative testing centre which 167 
would be outside of the scope of this audit.  The infection rate observed in our cohort of staff is 168 
comparable to the findings of Keehner et al. who found an infection rate of 0.4% from 14 days after 169 
the first dose of vaccine [10].  None of the staff members who completed the survey at UHCW had 170 
severe infection requiring hospital treatment.  This is reassuring and confirms data from studies that 171 
while not completely protective against infection, there is significant protection from hospitalisation 172 
and death [11].  Reassuringly, none of the staff who tested positive during the study period had two 173 
doses of vaccine.   174 
This is an evaluation looking at the vaccination status of our staff that tested positive for SARS-CoV-2 175 
in the period from the 8th December 2020 to the 13th March 2021.  This study showed that a low 176 
number of these infections (23 individuals) were from staff members who had been vaccinated in a 177 
time frame that would have been considered protective.    This gives confidence that the vaccination 178 
programme is a success.  However, we cannot comment on the longevity of protection offered from 179 
vaccination and the coverage that will be offered against new variants that arise.  Reassuringly, the 180 
staff members in this audit were vaccinated while there were still very high rates of transmission 181 
occurring in the community, and we were in the midst of a second wave with Alpha (B.1.1.7) being 182 
the predominant strain.  This wave peaked in the last week of January 2021.  So while this data 183 
offers real-world evidence that the vaccine is effective in preventing infections in health care 184 
workers, there is clearly need for further research into the impact of vaccination on the amount of 185 
         
virus present in the oro/nasopharynx and its role in transmission and whether this changes between 186 
different SARS-CoV-2 Variants.  187 
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Table I: Survey responses from staff members who tested positive for SARS-CoV-2 >14 days after vaccination.  
 





















on day of test 
New or additional 
symptoms within 3 























20 20 Siemens 
kPCR 
Fatigue None Confirmed 
case on ward. 






16 32 Siemens 
kPCR 
None None Confirmed 
case on ward. 
Portering 50 No White 
Irish 







Administration  19 No White 
British 
In contact 
with a person 
who was 
feeling unwell.  





































and health care 
assistant 
40 Yes Black 
African 
Symptomatic 24 33 STARlet 
Seegene 

















case on ward. 











18 34 Siemens 
kPCR 
None None Confirmed 
case on ward. 
Ward manager  33 Yes White 
British 






case on ward. 
Health Care 
Assistant 










Severe leg pains 
 
Confirmed 
case on ward. 






























case on ward. 
Health Care 
Assistant  
49 Yes British 
Indian 
















case on ward. 
Activities Co-
Ordinator 






69 29 STARlet 
Seegene 
None None Confirmed 
case on ward. 
SOB: shortness of breath 
*Cycle threshold (CT) values do not register the first 10 rounds of amplification.  Results obtained from the Abbott M2000 have been adjusted to reflect this (10 CT’s 
added).  Standard curves were not used to generate CT values.  
 
         
 
         
